Jivi and Omalizumab Subcutaneous
Determining the interaction of Jivi and Omalizumab Subcutaneous and the possibility of their joint administration.
No interaction was detected between the selected drugs or effects of joint drug administration are currently understudied, and it takes time and accumulated statistics to determine their interaction. A doctor should be consulted to address the issue of joint drug administration.
Generic Name: antihemophilic factor
Brand name: Jivi, Advate, Adynovate, Afstyla, Eloctate with Fc Fusion Protein, Helixate FS, Kogenate FS, Kovaltry, Novoeight, Nuwiq, Recombinate, Xyntha, Hemofil-M, Koate-DVI, Monoclate-P, Obizur
Synonyms: n.a.
Generic Name: omalizumab
Brand name: Xolair, Xolair Prefilled Syringe
Synonyms: Omalizumab
In the course of checking the drug compatibility and interactions, data from the following reference sources was used: Drugs.com, Rxlist.com, Webmd.com, Medscape.com.
- Jivi-Ombitasvir, Paritaprevir, and Ritonavir
- Jivi-Ombitasvir, paritaprevir, ritonavir and dasabuvir
- Jivi-Ombitasvir, Paritaprevir, Ritonavir, and Dasabuvir Extended-Release Tablets
- Jivi-Ombitasvir, Paritaprevir, Ritonavir, and Dasabuvir Tablets
- Jivi-Omeclamox-Pak
- Jivi-Omega-3 Fatty Acid Capsules
- Omalizumab Subcutaneous-Jivi Intravenous
- Omalizumab Subcutaneous-Jolessa
- Omalizumab Subcutaneous-Jolessa extended-cycle
- Omalizumab Subcutaneous-Jolivette
- Omalizumab Subcutaneous-Jornay PM
- Omalizumab Subcutaneous-Juleber